Nov 27, 2017
November 22nd, 2017 –
Veran Medical Technologies was recently featured in an article by Sky Ridge Medical Center. Read the full article here.
“Arteaga was told she could opt to wait another six months and see if the tumor grew more, as she had no lung-cancer risk factors, such as smoking. Or she could have Dr. Dunham remove the tumor with the SPiN Thoracic Navigation System™ available at Sky Ridge Medical Center.
The navigation system, much like a GPS, creates maps that guide surgeons and their electromagnetic instruments to lung nodules based on expiration CT scans rather than inhalation scans. The results of the newer technology, studies suggest, lead to more accurate lung nodule biopsies and removals.
“The system allows me to localize nodules that are even smaller than what an interventional radiologist can get to and then combine that with robotic surgery,” Dr. Dunham says. Minimally invasive robotic surgery involves three or four small incisions rather than a large, invasive incision opening up the chest cavity. “I was able to take the entire thing out, and it actually ended up being cancer.”
Without the navigation system technology, protocol would have been to wait six months or a year for a biopsy. “And at that point, it could have spread and been inoperable,” Dr. Dunham says of a common and frustrating scenario for option-less lung surgeons, which has contributed to lung cancer’s stagnant survival rates over the years.”
Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s main focus is assisting physicians in the early diagnosis and treatment of lung cancer. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined.
Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System™. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States. Veran provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked® instruments and Veran’s exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists.
Another challenge lung specialists face is that approximately 40% of lung nodules lie outside of an airway, making them very difficult to reach endobronchially, and traditionally requiring an additional procedure. Veran’s SPiN Thoracic Navigation System™ is the first and only FDA cleared technology that enables Pulmonologists or Thoracic Surgeons to safely and accurately access lung nodules outside of an airway using SPiN Perc™, a navigated transthoracic needle. With SPiN Perc™, Veran combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. The early diagnosis and treatment of lung cancer has been proven to save lives.
Media Inquiries: Please Contact TJ Meyer at email@example.com